Drug packaging – the primary differences between Europe and America to consider

Packaging has to match a number of purposes, such as: secure the goods, avoid theft, be economical, and uphold an equilibrium among its performance and its cost, both from the perspective of the material used and the time taken to form the packing.

From an environmental point of view, it is vital that materials are quickly recycled and employed as small as possible.
Exist numerous items on the market that may be confused with one other by cause of similar forms, colors or trademarks. Medicine packaging should vary considerably from sanitation and food products. For example, US tablet packaging confuses a medicine with a food, and that is not the best idea… for the user. Packaging for human medicines is one of the significant areas of design and investigation. So it is helpful to consider that, in this matter, there are obvious differences between the EU and the United States. Although health in the US is a subject of individuals and insurance economic concerns, in the majority of states in Europe it is governmental. This diversity modifies the manner in which medicines are perceived by the public. Therefore, US pharmacies sell a wide choice of drugs with a graphic pattern that in Europe is characteristic of more or less alimentary supplements.

On the other hand, in Europe, where the publicizing of drugs is much more severe, the tablet packaging tends to fave a more practical look, with no applause and no recommendations. The reason for this different approach in marketing messages is simple: the package’s target in Europe are doctors, while in the most of the US, the target of the package is the patient.